Objective: This study evaluated the effect of early application of intra-aortic balloon pump (IABP) counterpulsation in patients with ST-segment elevation acute myocardial infarction (STEMI), scheduled for elective percutaneous coronary intervention (PCI).

Methods: Patients who had experienced STEMI for 12-72 h received (IABP group) or did not receive (control group) IABP counterpulsation for 3-5 days before PCI.

Results: One hundred patients were included. Frequencies of infarct-related artery thrombolysis in acute myocardial infarction (TIMI) flow rate classes 0, I and II in the IABP group (11.5, 1.9 and 7.7%, respectively) were significantly lower than in the control group (29.1, 14.6 and 22.9%, respectively) before PCI. After PCI, the frequency of TIMI class III flow rate in the IABP group (96.2%) was significantly higher than that in the control group (81.3%). Four weeks after PCI, the left ventricular ejection fraction (LVEF) was significantly higher, and the incidence of major cardiac events was significantly lower, in the IABP group compared with the control group.

Conclusions: Early use of IABP counterpulsation in STEMI patients scheduled for PCI was effective, with a favourable safety profile. IABP counterpulsation reduced the incidence of major adverse cardiac events and improved LVEF. However, IABP devices must be used at an early stage, to obtain optimal results.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300060513476994DOI Listing

Publication Analysis

Top Keywords

iabp counterpulsation
16
iabp group
16
acute myocardial
12
myocardial infarction
12
control group
12
iabp
9
early application
8
application intra-aortic
8
intra-aortic balloon
8
balloon pump
8

Similar Publications

The intra-aortic balloon pump (IABP) is a widely-used mechanical circulatory support device that enhances hemodynamics in patients with heart conditions. Although the IABP is a common clinical tool, its effectiveness in enhancing outcomes for patients with acute myocardial infarction and cardiogenic shock remains disputed. This study aimed to assess the effectiveness of intra-aortic dual-balloon pump (IADBP) and its impact on aortic hemodynamics compared with an IABP.

View Article and Find Full Text PDF

Development of a Self-Deploying Extra-Aortic Compression Device for Medium-Term Hemodynamic Stabilization: A Feasibility Study.

Adv Sci (Weinh)

December 2024

Graduate School of Biomedical Engineering, Faculty of Engineering, and Tyree Institute of Health Engineering (IHealthE), UNSW Sydney, Kensington Campus, Sydney, NSW, 2052, Australia.

Hemodynamic stabilization is crucial in managing acute cardiac events, where compromised blood flow can lead to severe complications and increased mortality. Conditions like decompensated heart failure (HF) and cardiogenic shock require rapid and effective hemodynamic support. Current mechanical assistive devices, such as intra-aortic balloon pumps (IABP) and extracorporeal membrane oxygenation (ECMO), offer temporary stabilization but are limited to short-term use due to risks associated with prolonged blood contact.

View Article and Find Full Text PDF

[How to Insert an Intraaortic Balloon Pumping( IABP)].

Kyobu Geka

September 2024

Department of Cardiovascular Surgery, Kyorin University, Mitaka, Japan.

Article Synopsis
  • * Cardiovascular surgeons need to be skilled in the use and management of IABP, even though it's typically inserted by interventional cardiologists using radiofluoroscopic guidance.
  • * The paper outlines a safe approach for performing IABP insertion using transesophageal echocardiography (TEE) guidance, particularly in challenging situations during cardiac surgeries.
View Article and Find Full Text PDF

Background: The role of intra-aortic balloon pump (IABP) combined with venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock (CS) remains unclear. This study investigated the effect of applying IABP for left ventricle (LV) unloading after VA-ECMO on reducing mortality in patients with CS.

Methods: Data from 5,492 consecutive patients with CS treated with VA-ECMO between January 2017 and July 2023 were collected from the CSECLS registry.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates different strategies for venoarterial extracorporeal membrane oxygenation (V-A ECMO) in patients, examining the effectiveness of various cannulation sites and the use of intra-aortic balloon pump (IABP).
  • Researchers categorized patients into two main groups: those receiving isolated V-A ECMO and those receiving V-A ECMO with IABP, and further divided them based on cannulation sites (e.g., central, axillo-femoral).
  • Results showed no significant differences in organ perfusion across the different cannulation sites or with IABP support, suggesting that the choice of cannulation site should be tailored to individual patient needs rather than based on a one-size-fits-all approach
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!